Danaher acquired Beckman Coulter for $83.50 per share in cash (approximately $6.8 billion enterprise value including debt assumed), a 45% premium to Beckman Coulter's December 2010 closing price. Beckman Coulter, with $3.7 billion in annual revenues and over 200,000 systems installed worldwide, joined Danaher's Life Sciences & Diagnostics segment.